Health Idea Now
Thursday, 25 April 2019
Gilead's NASH drug fails to meet late-stage study goal
Gilead Sciences Inc said on Thursday its experimental drug to treat scarring of tissue due to nonalcoholic steatohepatitis (NASH) did not meet main goal of a late stage trial.
from Reuters: Health News https://reut.rs/2IVQbRG
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment